Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05537740
Title A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | CAN | BEL

Facility Status City State Zip Country Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Ohio State University WITHDRAWN Columbus Ohio 43210 United States Details
South Texas Accelerated Research Therapeutics | START San Antonio RECRUITING San Antonio Texas 78229-3307 United States Details
South Texas Accelerated Research Therapeutics | START Rocky Mountain Region RECRUITING West Valley City Utah 84119 United States Details
Antwerp University Hospital | Oncology Department NOT_YET_RECRUITING Antwerpen 2650 Belgium Details
Ghent University Hospital | Drug Research Unit Department NOT_YET_RECRUITING Gent 9000 Belgium Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2M9 Canada Details
National University Hospital NOT_YET_RECRUITING Singapore 119074 Singapore Details
National Cancer Center Singapore RECRUITING Singapore 169610 Singapore Details
Royal Marsden NHS Trust (Surrey) NOT_YET_RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
The Christie NHS Foundation Trust - Christie Hospital NOT_YET_RECRUITING Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field